Keyword: Akili Interactive

Merck, Amgen bump up Series B to $42.4M for Akili

Akili Interactive Labs, the Boston-based startup developing nonpharmacological therapeutics for various cognitive disorders like autism and Alzheimer’s disease, got an $11.9 million boost in funding, raising its total Series B proceeds to $42.4 million.